Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
3.040
-0.110 (-3.49%)
At close: Feb 4, 2025, 4:00 PM
3.060
+0.020 (0.66%)
Pre-market: Feb 5, 2025, 7:00 AM EST
Solid Biosciences Stock Forecast
SLDB's stock price has decreased by -56.7% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Solid Biosciences stock have an average target of 17.75, with a low estimate of 12 and a high estimate of 40. The average target predicts an increase of 483.88% from the current stock price of 3.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Solid Biosciences stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 4 |
| Buy | 7 | 7 | 7 | 6 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +426.32% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +426.32% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +426.32% | Jan 8, 2025 |
| Wedbush | Wedbush | Buy Initiates $16 | Buy | Initiates | $16 | +426.32% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +426.32% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
255.00K
EPS This Year
-3.00
from -4.83
EPS Next Year
-3.01
from -3.00
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 3.2M | n/a | |||
| Avg | n/a | 255,000 | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.79 | -2.13 | -1.98 | |||
| Avg | -3.00 | -3.01 | -2.90 | |||
| Low | -3.88 | -4.15 | -4.51 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.